Corvex (NASDAQ:MOVE) Upgraded to “Strong-Buy” at Chardan Capital

Chardan Capital upgraded shares of Corvex (NASDAQ:MOVEFree Report) to a strong-buy rating in a research note released on Wednesday morning,Zacks reports.

MOVE has been the topic of a number of other reports. Wall Street Zen upgraded shares of Corvex from a “sell” rating to a “hold” rating in a research report on Sunday, May 24th. Weiss Ratings raised shares of Corvex from a “sell (d-)” rating to a “sell (d)” rating in a research note on Thursday, September 3rd. One analyst has rated the stock with a Strong Buy rating and one has issued a Sell rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $18.75.

Get Our Latest Stock Analysis on MOVE

Corvex Price Performance

MOVE opened at $10.92 on Wednesday. The company has a current ratio of 1.80, a quick ratio of 1.80 and a debt-to-equity ratio of 4.28. The stock has a market capitalization of $344.53 million, a P/E ratio of -0.58 and a beta of 0.90. The stock has a 50-day moving average price of $12.20 and a 200-day moving average price of $15.32. Corvex has a 12-month low of $3.44 and a 12-month high of $26.72.

Corvex (NASDAQ:MOVEGet Free Report) last announced its quarterly earnings data on Friday, August 14th. The AI infrastructure company reported ($5.12) earnings per share for the quarter, missing analysts’ consensus estimates of ($3.17) by ($1.95). The company had revenue of $3.80 million during the quarter, compared to the consensus estimate of $6.71 million.

Corvex Company Profile

(Get Free Report)

Movano Inc engages in developing a platform to deliver healthcare solutions at the intersection of medical and consumer devices. The company is involved in the development of Evie Ring, which is a wearable designed specifically for women that combines health and wellness metrics comprises resting heart rate, heart rate variability (HRV), blood oxygen saturation (SpO2), respiration rate, skin temperature variability, period and ovulation tracking, and menstrual symptom tracking, as well as activity profile, including steps, active minutes and calories burned, sleep stages and duration, and mood tracking.

Recommended Stories

Receive News & Ratings for Corvex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corvex and related companies with MarketBeat.com's FREE daily email newsletter.